The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

SMURF1  -  SMAD specific E3 ubiquitin protein ligase 1

Homo sapiens

Synonyms: E3 ubiquitin-protein ligase SMURF1, KIAA1625, SMAD ubiquitination regulatory factor 1, SMAD-specific E3 ubiquitin-protein ligase 1, hSMURF1
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of SMURF1

 

High impact information on SMURF1

 

Biological context of SMURF1

  • Here we identified a functional nuclear export signal (NES) in a C-terminal region of Smurf1 [6].
  • Finally, the Smurf1 NES mutant reduced inhibition by Smad7 of the transcriptional activation induced by TGF-beta [6].
  • In previous studies we discovered that E3 ubiquitin ligase Smad ubiquitin regulatory factor 1 (Smurf1) induces Runx2 degradation in a ubiquitin-proteasome-dependent manner, and Smurf1 plays an important role in osteoblast function and bone formation [7].
  • We determined that LMP-1, a LIM domain protein capable of inducing de novo bone formation, interacts with Smurf1 (Smad ubiquitin regulatory factor 1) and prevents ubiquitination of Smads [8].
  • Previous work has demonstrated in non-neuronal cell types that Smurf1, an E3 ubiquitin ligase, regulates cell polarity and protrusive activity via PKCzeta-dependent recruitment to cellular protrusion sites, and subsequent ubiquitination and proteasomal degradation of RhoA [1].
 

Anatomical context of SMURF1

  • We show here that Smurf1 targets Smad7 to the plasma membrane through its N-terminal conserved 2 (C2) domain [9].
  • We demonstrate that ectopic expression of Smurf1 in Vero cells, deficient for RhoA ubiquitylation, restores ubiquitylation of the activated forms of RhoA [10].
  • We conclude here that Smurf1 ubiquitylates activated RhoA and that, in contrast to human primary cell types, some cancer cell lines have a lower ubiquitylation capacity of specific Rho proteins [10].
  • Smurf1, in turn, targets the guanosine triphosphatase RhoA for degradation, thereby leading to a loss of tight junctions [11].
 

Associations of SMURF1 with chemical compounds

 

Physical interactions of SMURF1

  • Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation [13].
  • Smurf1 also interacts directly with either nucleotide-free or GDP-bound RhoA in vitro; however, loading with GTPgammaS inhibits the interaction [14].
 

Regulatory relationships of SMURF1

 

Other interactions of SMURF1

  • However, the mechanism of nuclear export of Smad7 by Smurf1 has not been elucidated [6].
  • Genetic analysis has revealed that Runx2 is degraded through a Smurf-mediated ubiquitination pathway, and its activity is inhibited by HDAC4 [17].
  • Smurf1 has been shown to interact with Smads 1, 5, 6, and 7, and Smads 1 and 5 also interact with Runx2 [7].
  • LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads [8].
  • It has been reported that Smurf1, a member of the Hect family E3 ubiquitin ligases, can target Smad1 to 26S proteasome for degradation [18].

References

  1. Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. Bryan, B., Cai, Y., Wrighton, K., Wu, G., Feng, X.H., Liu, M. FEBS Lett. (2005) [Pubmed]
  2. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Yamashita, M., Ying, S.X., Zhang, G.M., Li, C., Cheng, S.Y., Deng, C.X., Zhang, Y.E. Cell (2005) [Pubmed]
  3. Control of Smad7 stability by competition between acetylation and ubiquitination. Grönroos, E., Hellman, U., Heldin, C.H., Ericsson, J. Mol. Cell (2002) [Pubmed]
  4. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. Asano, Y., Ihn, H., Yamane, K., Kubo, M., Tamaki, K. J. Clin. Invest. (2004) [Pubmed]
  5. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. Sahai, E., Garcia-Medina, R., Pouyss??gur, J., Vial, E. J. Cell Biol. (2007) [Pubmed]
  6. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-beta signaling by Smad7. Tajima, Y., Goto, K., Yoshida, M., Shinomiya, K., Sekimoto, T., Yoneda, Y., Miyazono, K., Imamura, T. J. Biol. Chem. (2003) [Pubmed]
  7. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. Shen, R., Chen, M., Wang, Y.J., Kaneki, H., Xing, L., O'keefe, R.J., Chen, D. J. Biol. Chem. (2006) [Pubmed]
  8. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. Sangadala, S., Boden, S.D., Viggeswarapu, M., Liu, Y., Titus, L. J. Biol. Chem. (2006) [Pubmed]
  9. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. Suzuki, C., Murakami, G., Fukuchi, M., Shimanuki, T., Shikauchi, Y., Imamura, T., Miyazono, K. J. Biol. Chem. (2002) [Pubmed]
  10. CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in Smurf1-/- cells. Boyer, L., Turchi, L., Desnues, B., Doye, A., Ponzio, G., Mege, J.L., Yamashita, M., Zhang, Y.E., Bertoglio, J., Flatau, G., Boquet, P., Lemichez, E. Mol. Biol. Cell (2006) [Pubmed]
  11. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.R., Zhang, Y., Wrana, J.L. Science (2005) [Pubmed]
  12. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. Jin, Y.H., Jeon, E.J., Li, Q.L., Lee, Y.H., Choi, J.K., Kim, W.J., Lee, K.Y., Bae, S.C. J. Biol. Chem. (2004) [Pubmed]
  13. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., Miyazono, K. J. Biol. Chem. (2001) [Pubmed]
  14. Degradation of RhoA by Smurf1 ubiquitin ligase. Wang, H.R., Ogunjimi, A.A., Zhang, Y., Ozdamar, B., Bose, R., Wrana, J.L. Meth. Enzymol. (2006) [Pubmed]
  15. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Zhu, X., Topouzis, S., Liang, L.F., Stotish, R.L. Cytokine (2004) [Pubmed]
  16. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. Fukunaga, E., Inoue, Y., Komiya, S., Horiguchi, K., Goto, K., Saitoh, M., Miyazawa, K., Koinuma, D., Hanyu, A., Imamura, T. J. Biol. Chem. (2008) [Pubmed]
  17. Bone morphogenetic protein-2 stimulates Runx2 acetylation. Jeon, E.J., Lee, K.Y., Choi, N.S., Lee, M.H., Kim, H.N., Jin, Y.H., Ryoo, H.M., Choi, J.Y., Yoshida, M., Nishino, N., Oh, B.C., Lee, K.S., Lee, Y.H., Bae, S.C. J. Biol. Chem. (2006) [Pubmed]
  18. Specific interaction between Smad1 and CHIP: a surface plasmon resonance study. Li, R.F., Zhang, F., Lu, Y.J., Sui, S.F. Colloids and surfaces. B, Biointerfaces. (2005) [Pubmed]
 
WikiGenes - Universities